Motley Fool Wealth Management LLC decreased its stake in Rxo Inc (NYSE:RXO – Free Report) by 83.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 66,090 shares of the company’s stock after selling 344,440 shares during the quarter. Motley Fool Wealth Management LLC’s holdings in RXO were worth $835,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Geneos Wealth Management Inc. purchased a new position in shares of RXO in the 1st quarter worth approximately $30,000. Flagship Harbor Advisors LLC purchased a new position in shares of RXO in the 4th quarter worth approximately $25,000. Quarry LP purchased a new position in shares of RXO in the 3rd quarter worth approximately $33,000. Larson Financial Group LLC boosted its holdings in shares of RXO by 146.5% in the 3rd quarter. Larson Financial Group LLC now owns 2,766 shares of the company’s stock worth $43,000 after purchasing an additional 1,644 shares during the period. Finally, Jones Financial Companies Lllp boosted its holdings in shares of RXO by 27.0% in the 3rd quarter. Jones Financial Companies Lllp now owns 3,298 shares of the company’s stock worth $49,000 after purchasing an additional 701 shares during the period. Hedge funds and other institutional investors own 92.73% of the company’s stock.
RXO Price Performance
RXO opened at $28.83 on Thursday. The business has a fifty day moving average of $20.78 and a 200 day moving average of $16.58. Rxo Inc has a 52-week low of $10.43 and a 52-week high of $29.86. The company has a quick ratio of 1.27, a current ratio of 1.27 and a debt-to-equity ratio of 0.28. The stock has a market cap of $4.76 billion, a P/E ratio of -47.27, a PEG ratio of 30.91 and a beta of 2.08.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on RXO. Barclays lifted their target price on RXO from $17.00 to $20.00 and gave the stock an “overweight” rating in a report on Friday, May 8th. Truist Financial lifted their target price on RXO from $20.00 to $26.00 and gave the stock a “buy” rating in a report on Friday, May 8th. UBS Group lifted their target price on RXO from $17.00 to $22.00 and gave the stock a “neutral” rating in a report on Friday, May 8th. The Goldman Sachs Group reiterated a “neutral” rating and issued a $18.00 target price on shares of RXO in a report on Friday, May 8th. Finally, Susquehanna lifted their target price on RXO from $14.00 to $18.00 and gave the stock a “negative” rating in a report on Friday, May 8th. Three analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $20.08.
Check Out Our Latest Analysis on RXO
About RXO
RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
Featured Articles
- Five stocks we like better than RXO
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Want to see what other hedge funds are holding RXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rxo Inc (NYSE:RXO – Free Report).
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.
